ranitidine has been researched along with Heart Valve Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández, MA; Romá, E | 1 |
| Laínez, RM; Losada, M; Nieto, E; Olona, M | 1 |
| Ali, MJ; Badner, NH; Watson, JT | 1 |
3 other study(ies) available for ranitidine and Heart Valve Diseases
| Article | Year |
|---|---|
International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Blood Proteins; Drug Administration Schedule; Drug Synergism; Erectile Dysfunction; Gingival Hemorrhage; Half-Life; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Piperazines; Postoperative Complications; Protein Binding; Purines; Ranitidine; Sildenafil Citrate; Sulfones; Thrombosis; Warfarin | 2003 |
[Pneumonia in patients undergoing heart surgery].
Topics: Adult; Aged; Cardiac Surgical Procedures; Comorbidity; Cross Infection; Female; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Incidence; Intubation, Intratracheal; Lung Diseases, Obstructive; Male; Middle Aged; Myocardial Ischemia; Pneumonia; Postoperative Complications; Prospective Studies; Pulmonary Atelectasis; Ranitidine; Risk Factors | 1994 |
The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Carcinoid Tumor; Female; Heart Valve Diseases; Humans; Intraoperative Complications; Middle Aged; Octreotide; Ovarian Neoplasms; Premedication; Ranitidine | 1990 |